HIMS EPS
Net income divided by diluted shares outstanding — the per-share profit earned each quarter.
EPS
Latest: −$0.37 (2026Q2)
| Period | Value |
|---|---|
| 2020Q4 | −$0.07 |
| 2021Q1 | −$0.34 |
| 2021Q2 | −$0.05 |
| 2021Q3 | −$0.08 |
| 2021Q4 | −$0.15 |
| 2022Q1 | −$0.08 |
| 2022Q2 | −$0.10 |
| 2022Q3 | −$0.09 |
| 2022Q4 | −$0.05 |
| 2023Q1 | −$0.05 |
| 2023Q2 | −$0.03 |
| 2023Q3 | −$0.04 |
| 2023Q4 | $0.01 |
| 2024Q1 | $0.05 |
| 2024Q2 | $0.06 |
| 2024Q3 | $0.32 |
| 2024Q4 | $0.11 |
| 2025Q1 | $0.20 |
| 2025Q2 | $0.17 |
| 2025Q3 | $0.06 |
| 2025Q4 | $0.08 |
| 2026Q1 | −$0.40 |
| 2026Q2 | −$0.37 |
Other HIMS Charts
More quarter-by-quarter fundamentals for Hims & Hers Health, Inc.
1 / 10
Revenue
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Latest EPS: −$0.37 (2026Q2).
Across the 23 quarters from 2020Q4 to 2026Q2, EPS ranged from −$0.40 in 2026Q1 to $0.32 in 2024Q3.